LCD ID Number: L37663 Status: A-Approved
LCD Title: MolDX: EndoPredict® Breast Cancer Gene Expression Test
Geographic Jurisdiction: Missouri - Entire State, Missouri - Northwestern Other Jurisdictions
Original Determination Effective Date:
08/16/2018
Original Determination Ending Date:
Revision Effective Date:
05/01/2025
Revision End Date:
CMS National Coverage Policy:
Title XVIII of the Social Security Act, §1862(a)(1)(A). Allows coverage and payment for only those services that are considered to be reasonable and necessary.
42 Code of Federal Regulations (CFR) §410.32 Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions
Sorry, you need to login or register to view additional sections of this Medicare policy.
*
|